Imofinostat

N/A

Report date: 2025/08/05 17:46:00
NME

Base Information

Drug NameImofinostat
Drug Alias NameMPT-0E028TMU-C-0012ABT-301MPT0E028TSY-410
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 inhibitorsHistone deacetylase 2 inhibitorsHistone deacetylase 3 inhibitors
TargetsHistone deacetylase 1Histone deacetylase 2Histone deacetylase 3
Therapy Area/IndicationsSolid tumoursRectal NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaipei Medical UniversityFormosa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnbogen Therapeutics Inc
Inactive CompaniesTaipei Medical University
Active IndicationsRectal NeoplasmsColorectal Neoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A